Axa’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
263,233
+424
| +0.2% | +$3.99K | 0.01% | 731 |
|
|
2025
Q1 | $1.42M | Sell |
262,809
-334
| -0.1% | -$1.81K | ﹤0.01% | 796 |
|
|
2024
Q4 | $1.96M | Sell |
263,143
-415
| -0.2% | -$3.09K | 0.01% | 757 |
|
|
2024
Q3 | $2.11M | Buy |
263,558
+75
| +0% | +$599 | 0.01% | 732 |
|
|
2024
Q2 | $2.29M | Buy |
263,483
+148
| +0.1% | +$1.29K | 0.01% | 726 |
|
|
2024
Q1 | $5.44M | Sell |
263,335
-23,808
| -8% | -$492K | 0.02% | 540 |
|
|
2023
Q4 | $6.64M | Sell |
287,143
-6,948
| -2% | -$161K | 0.02% | 487 |
|
|
2023
Q3 | $2.35M | Buy |
294,091
+64,678
| +28% | +$517K | 0.01% | 683 |
|
|
2023
Q2 | $2M | Buy |
+229,413
| New | +$2M | 0.01% | 729 |
|